Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to Michael Birrer

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Birrer, Michael

Item TypeName
Academic Article Gene expression profiles of serous, endometrioid, and clear cell subtypes of ovarian and endometrial cancer.
Academic Article Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers.
Concept Carcinoma, Squamous Cell
Concept Carcinoma, Papillary
Concept Carcinoma
Concept Carcinoma in Situ
Concept Carcinoma, Transitional Cell
Concept Carcinoma, Renal Cell
Concept Carcinoma, Hepatocellular
Concept Carcinoma, Non-Small-Cell Lung
Concept Carcinoma, Small Cell
Concept Carcinoma, Endometrioid
Academic Article Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.
Academic Article A phase I study of the PARP inhibitor niraparib in combination with bevacizumab in platinum-sensitive epithelial ovarian cancer: NSGO AVANOVA1/ENGOT-OV24.
Academic Article Tissue-based immune monitoring I: tumor core needle biopsies allow in-depth interrogation of the tumor microenvironment.
Academic Article Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma.
Academic Article Patterns of recurrence in patients treated with bevacizumab in the primary treatment of advanced epithelial ovarian cancer.
Academic Article Wnt5a suppresses epithelial ovarian cancer by promoting cellular senescence.
Academic Article Inherited Mutations in Women With Ovarian Carcinoma.
Academic Article Making a Difference: Distinguishing Two Primaries From Metastasis in Synchronous Tumors of the Ovary and Uterus.
Academic Article Characterization of folate receptor alpha (FRa) expression in archival tumor and biopsy samples from relapsed epithelial ovarian cancer patients: A phase I expansion study of the FRa-targeting antibody-drug conjugate mirvetuximab soravtansine.
Academic Article Somatic Mosaic Mutations in PPM1D and TP53 in the Blood of Women With Ovarian Carcinoma.
Academic Article Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study.
Academic Article Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group Study.
Academic Article A gene signature predicting for survival in suboptimally debulked patients with ovarian cancer.
Academic Article Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary.
Academic Article Overexpression of enhance of Zeste homolog 2 (EZH2) in endometrial carcinoma: An NRG Oncology/Gynecologic Oncology Group Study.
Academic Article Mutations in Homologous Recombination Genes and Outcomes in Ovarian Carcinoma Patients in GOG 218: An NRG Oncology/Gynecologic Oncology Group Study.
Academic Article Multi-gene expression predictors of single drug responses to adjuvant chemotherapy in ovarian carcinoma: predicting platinum resistance.
Academic Article Better therapeutic trials in ovarian cancer.
Academic Article Genome wide DNA copy number analysis of serous type ovarian carcinomas identifies genetic markers predictive of clinical outcome.
Academic Article Dysregulated microRNAs and their predicted targets associated with endometrioid endometrial adenocarcinoma in Hong Kong women.
Academic Article Clear cell carcinoma of the ovary: a review of the literature.
Academic Article BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group.
Academic Article NORE1A tumor suppressor candidate modulates p21CIP1 via p53.
Academic Article Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study.
Academic Article An RNA interference lethality screen of the human druggable genome to identify molecular vulnerabilities in epithelial ovarian cancer.
Academic Article Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma.
Academic Article Consensus on Molecular Subtypes of High-Grade Serous Ovarian Carcinoma.
Academic Article Ovarian cancer: markers of response.
Academic Article Low-grade and high-grade serous Mullerian carcinoma: review and analysis of publicly available gene expression profiles.
Academic Article Prognostically relevant gene signatures of high-grade serous ovarian carcinoma.
Academic Article Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study.
Academic Article Phase II study of the PI3K inhibitor pilaralisib (SAR245408; XL147) in patients with advanced or recurrent endometrial carcinoma.
Academic Article Overexpression of elafin in ovarian carcinoma is driven by genomic gains and activation of the nuclear factor kappaB pathway and is associated with poor overall survival.
Academic Article Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31.
Academic Article Multiplex profiling identifies distinct local and systemic alterations during intraperitoneal chemotherapy for ovarian cancer: An NRG Oncology/Gynecologic Oncology Group Study.
Academic Article High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study.
Academic Article Early events in the pathogenesis of epithelial ovarian cancer.
Academic Article An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: An NRG Oncology/Gynecologic Oncology Group experience.
Academic Article DNA copy number abnormality of oral squamous cell carcinoma detected with cDNA array-based comparative genomic hybridization.
Academic Article The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing.
Academic Article Role of molecular agents and targeted therapy in clinical trials for women with ovarian cancer.
Academic Article Mutation of ERBB2 provides a novel alternative mechanism for the ubiquitous activation of RAS-MAPK in ovarian serous low malignant potential tumors.
Academic Article Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer.
Academic Article FORWARD I: a Phase III study of mirvetuximab soravtansine versus chemotherapy in platinum-resistant ovarian cancer.
Academic Article Ovarian cancer: targeting the untargetable.
Academic Article Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
Academic Article Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma.
Academic Article Incorporation of bevacizumab in the primary treatment of ovarian cancer.
Academic Article Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: a Gynecologic Oncology Group study.
Academic Article Identification of a potential ovarian cancer stem cell gene expression profile from advanced stage papillary serous ovarian cancer.
Academic Article Ovarian cancer risk associated with inherited inflammation-related variants.
Academic Article Predictive Blood-Based Biomarkers in Patients with Epithelial Ovarian Cancer Treated with Carboplatin and Paclitaxel with or without Bevacizumab: Results from GOG-0218.
Academic Article Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG Oncology study (NRG-GY008).
Academic Article CD44 Splice Variant v8-10 as a Marker of Serous Ovarian Cancer Prognosis.
Academic Article Phase 1 and 2 study of carboplatin and pralatrexate in patients with recurrent, platinum-sensitive ovarian, fallopian tube, or primary peritoneal cancer.
Academic Article FGFR2 mutations are rare across histologic subtypes of ovarian cancer.
Academic Article The regulation of tumor suppressor genes by oncogenes.
Academic Article Ovarian cancer: not a borderline issue!
Academic Article CD157 in ovarian carcinoma: how does it help us?
Academic Article SUZ12 promotes human epithelial ovarian cancer by suppressing apoptosis via silencing HRK.
Academic Article Is Targeting the Folate Receptor in Ovarian Cancer Coming of Age?
Academic Article Uterine papillary serous cancer: a review of the literature.
Academic Article Minichromosome maintenance (MCM) protein 4 as a marker for proliferation and its clinical and clinicopathological significance in non-small cell lung cancer.
Academic Article Activity of sorafenib in recurrent ovarian cancer and primary peritoneal carcinomatosis: a gynecologic oncology group trial.
Academic Article Olaparib and a-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial.
Academic Article Phase 1 dose-escalation study of mirvetuximab soravtansine (IMGN853), a folate receptor a-targeting antibody-drug conjugate, in patients with solid tumors.
Academic Article Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathways.
Academic Article A functional variant in HOXA11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer.
Academic Article LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer.
Academic Article Etiology and pathogenesis of epithelial ovarian cancer.
Academic Article A Phase 1 trial of the poly(ADP-ribose) polymerase inhibitor olaparib (AZD2281) in combination with the anti-angiogenic cediranib (AZD2171) in recurrent epithelial ovarian or triple-negative breast cancer.
Academic Article MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium.
Academic Article Phase Ib study of mirvetuximab soravtansine, a folate receptor alpha (FRa)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer.
Academic Article Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
Academic Article Multiomic Analysis of Subtype Evolution and Heterogeneity in High-Grade Serous Ovarian Carcinoma.
Grant The Molecular Genetics of Gynecologic Cancers
Academic Article Candidate biomarkers for application as intermediate end points of lung carcinogenesis.
Academic Article Structure and expression of the human L-myc gene reveal a complex pattern of alternative mRNA processing.
Academic Article Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer.
Academic Article Translational research and epithelial carcinogenesis: molecular diagnostic assays now--molecular screening assays soon?
Academic Article Occurrence of p53 gene abnormalities in gastric carcinoma tumors and cell lines.
Academic Article Expression of the atrial natriuretic factor gene in small cell lung cancer tumors and tumor cell lines.
Academic Article p53: a frequent target for genetic abnormalities in lung cancer.
Academic Article p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Academic Article Initiators and promoters of lung cancer.
Academic Article PACAP stimulates c-fos mRNAs in small cell lung cancer cells.
Academic Article Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells.
Academic Article The molecular genetics of gyn malignancies.
Academic Article Bombesin stimulates c-fos and c-jun mRNAs in small cell lung cancer cells.
Academic Article Altered cJUN expression: an early event in human lung carcinogenesis.
Academic Article Frequent loss of KAI1 expression in squamous and lymphoid neoplasms. An immunohistochemical study of archival tissues.
Academic Article p27 and cyclin D1 abnormalities in uterine papillary serous carcinoma.
Academic Article Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
Academic Article Age-specific survival of women with endometrioid adenocarcinoma of the uterus.
Academic Article The role of p27 in endometrial carcinoma.
Academic Article In situ detection of unexpected patterns of mutant p53 gene expression in non-small cell lung cancers.
Academic Article Growth inhibition of non-small cell lung cancer cells by AP-1 blockade using a cJun dominant-negative mutant.
Academic Article Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cells.
Academic Article Epithelial ovarian cancer: the molecular genetics of epithelial ovarian cancer.
Academic Article Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study.
Academic Article How can molecular abnormalities influence our clinical approach.
Academic Article Final report on serial phase II trials of all-intraperitoneal chemotherapy with or without bevacizumab for women with newly diagnosed, optimally cytoreduced carcinoma of M?llerian origin.
Academic Article Corrigendum to "Phase II evaluation of copanlisib, a selective inhibitor of Pi3kca, in patients with persistent or recurrent endometrial carcinoma harboring PIK3CA hotspot mutations: An NRG oncology study (NRG-GY008)" [Gynecol. Oncol. Rep. 31 (2020) 100532].
Academic Article Neutralization of TGF? Improves Tumor Immunity and Reduces Tumor Progression in Ovarian Carcinoma.
Academic Article Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary?analysis of FORWARD I.
Academic Article Correlation of imaging and plasma based biomarkers to predict response to bevacizumab in epithelial ovarian cancer (EOC).
Academic Article Quality of Life and Adverse Events: Prognostic Relationships in Long-Term Ovarian Cancer Survival.
Academic Article Understanding the effect of mechanical forces on ovarian cancer progression.
Academic Article Sequential Phase II clinical trials evaluating CRLX101 as monotherapy and in combination with bevacizumab in recurrent ovarian cancer.
Academic Article Chemotherapy with or without avelumab followed by avelumab maintenance versus chemotherapy alone in patients with previously untreated epithelial ovarian cancer (JAVELIN Ovarian 100): an open-label, randomised, phase 3 trial.
Academic Article Impact of homologous recombination status and responses with veliparib combined with first-line chemotherapy in ovarian cancer in the Phase 3 VELIA/GOG-3005 study.
Academic Article Fear of recurrence, emotional well-being and quality of life among long-term advanced ovarian cancer survivors.
Academic Article LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma.
Academic Article Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer.
Academic Article DKK1 is a predictive biomarker for response to DKN-01: Results of a phase 2 basket study in women with recurrent endometrial carcinoma.
Academic Article Molecular determinants of clinical outcomes of pembrolizumab in recurrent ovarian cancer: Exploratory analysis of KEYNOTE-100.

Search Criteria
  • Carcinoma